Allogene Therapeutics, Inc.
ALLO
13 insider filings · Latest: Apr 21, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Apr 23 8:16 PM | Annie YoshiyamaSVP, Finance | Sale | 9,586 | $2.31 | $22.1K | 124,517(D) | View → |
| Apr 21, 2026 | Apr 22 12:22 AM | Yoshiyama Annie | Proposed Sale | 9,586 | $2.31 | $22.1K | — | View → |
| Mar 31, 2026 | Apr 2 8:47 PM | Benjamin Machinas BeneskiSVP, Chief Technical Officer | Sale | 2,867 | $2.50 | $7.2K | 195,338(D) | View → |
| Apr 1, 2026 | Apr 1 11:13 PM | Beneski Benjamin Machinas | Proposed Sale | 2,867 | $2.50 | $7.2K | — | View → |
| Mar 16, 2026 | Mar 18 8:06 PM | Benjamin Machinas BeneskiSVP, Chief Technical Officer | Sale | 4,835 | $2.47 | $11.9K | 198,205(D) | View → |
| Mar 16, 2026 | Mar 18 8:05 PM | Chang David DDirector, President and CEO | Sale | 47,763 | $2.47 | $118.0K | 5,150,599(D) | View → |
| Mar 16, 2026 | Mar 17 12:20 AM | Beneski Benjamin Machinas | Proposed Sale | 4,835 | $2.47 | $11.9K | — | View → |
| Mar 16, 2026 | Mar 17 12:05 AM | Chang David D | Proposed Sale | 47,763 | $2.47 | $117.8K | — | View → |
| Mar 2, 2026 | Mar 4 10:42 PM | Benjamin Machinas BeneskiSVP, Chief Technical Officer | Sale | 7,132 | $2.60 | $18.5K | 203,040(D) | View → |
| Mar 2, 2026 | Mar 3 2:04 AM | Beneski Benjamin Machinas | Proposed Sale | 7,132 | $2.60 | $18.5K | — | View → |
| Feb 2, 2026 | Feb 4 10:20 PM | Benjamin Machinas BeneskiSVP, Chief Technical Officer | Sale | 7,549 | $1.73 | $13.1K | 210,172(D) | View → |
| Feb 2, 2026 | Feb 4 10:18 PM | Chang David DDirector, President and CEO | Sale | 95,269 | $1.80 | $171.5K | 5,185,862(D) | View → |
| Feb 2, 2026 | Feb 4 10:16 PM | Geoffrey M. ParkerCHIEF FINANCIAL OFFICER | Sale | 24,001 | $1.76 | $42.2K | 1,252,795(D) | View → |
| Feb 2, 2026 | Feb 4 10:12 PM | Earl Martin DouglasSVP, General Counsel | Sale | 22,900 | $1.76 | $40.3K | 564,948(D) | View → |
| Feb 2, 2026 | Feb 4 10:09 PM | Annie YoshiyamaSVP, Finance | Sale | 4,167 | $1.72 | $7.2K | 130,322(D) | View → |
| Feb 2, 2026 | Feb 4 10:07 PM | Zachary RobertsEVP of R&D | Sale | 35,700 | $1.77 | $63.2K | 581,166(D) | View → |
| Feb 2, 2026 | Feb 2 10:17 PM | EARL DOUGLAS | Proposed Sale | 22,900 | $1.76 | $40.2K | — | View → |
| Feb 2, 2026 | Feb 2 10:16 PM | GEOFFREY M PARKER | Proposed Sale | 24,001 | $1.76 | $42.2K | — | View → |
| Feb 2, 2026 | Feb 2 10:16 PM | ZACHARY J ROBERTS | Proposed Sale | 35,700 | $1.77 | $63.4K | — | View → |
| Feb 2, 2026 | Feb 2 10:15 PM | ANNIE T YOSHIYAMA | Proposed Sale | 4,167 | $1.72 | $7.2K | — | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Feb 4 10:20 PM | Benjamin Machinas BeneskiSVP, Chief Technical Officer | Grant/Award | 479,477 | $1.87 | 105,720(D) | View → |
| Feb 2, 2026 | Feb 4 10:18 PM | Chang David DDirector, President and CEO | Grant/Award | 1,780,517 | $1.87 | 392,586(D) | View → |
| Feb 2, 2026 | Feb 4 10:16 PM | Geoffrey M. ParkerCHIEF FINANCIAL OFFICER | Grant/Award | 691,552 | $1.87 | 152,480(D) | View → |
| Feb 2, 2026 | Feb 4 10:12 PM | Earl Martin DouglasSVP, General Counsel | Grant/Award | 691,552 | $1.87 | 152,480(D) | View → |
| Feb 2, 2026 | Feb 4 10:09 PM | Annie YoshiyamaSVP, Finance | Grant/Award | 230,518 | $1.87 | 50,827(D) | View → |
| Feb 2, 2026 | Feb 4 10:07 PM | Zachary RobertsEVP of R&D | Grant/Award | 922,070 | $1.87 | 203,307(D) | View → |
| Feb 2, 2026 | Feb 4 10:04 PM | Arie BelldegrunDirector | Grant/Award | 1,192,946 | $1.87 | 263,033(D) | View → |